{{Rsnum
|rsid=6809699
|Gene=P2RY12
|Chromosome=3
|position=151338810
|Orientation=plus
|ReferenceAllele=T
|GMAF=0.1097
|Gene_s=MED12L,P2RY12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 2.7 | 31.9 | 65.5
| HCB | 2.9 | 24.1 | 73.0
| JPT | 0.9 | 20.4 | 78.8
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 8.8 | 91.2
| CHB | 2.9 | 24.1 | 73.0
| CHD | 2.8 | 19.3 | 78.0
| GIH | 1.0 | 17.8 | 81.2
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 12.1 | 86.2
| MKK | 0.0 | 0.0 | 0.0
| TSI | 2.0 | 18.6 | 79.4
| HapMapRevision=28
}}{{PMID|17707382}}  [[rs10935838]], [[rs2046934]], [[rs5853517]], and [[rs6809699]]  [[venous thromboembolism]] lower risk of incident DVT/PE as compared to the reference haplotype H1 (odds ratio=0.50, 95% CI=0.27-0.93, p=0.028)

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}